Management of women with high grade CIN/CGIN on initial biopsy (N = 50) | |
Treatment | Number (%) |
LLETZ Active surveillance Care transferred to another provider Patient did not attend for follow-up | 40 (80.0) 7 (14.0) 2 (4.0) 1 (2.0) |
Histology results from LLETZ samples (N = 40) | |
Result | Number (%) |
No residual CIN CIN 1 CIN 2 CIN 3 Ungraded CIN High grade CGIN Adenocarcinoma | 1 (2.5) 9 (22.5) 15 (37.5) 10 (25.0) 3 (7.5) 1 (2.5) 1 (2.5) |